Kidney function, albuminuria and life expectancy

Canadian Journal of Kidney Health and Disease

Volumn 1, Issue 1, 2014, Pages

  Turin, Tanvir Chowdhury ^a,b   Ahmed, Sofia B ^a,b   Tonelli, Marcello ^c   Manns, Braden ^a,b   Ravani, Pietro ^a,b   James, Matthew ^a,b   Quinn, Robert R ^a,b   Jun, Min ^a   Gansevoort, Ron ^d   Hemmelgarn, Brenda ^a,b  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

^c UNIVERSITY OF ALBERTA   (Canada)

^d UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ALBUMINURIA; ARTICLE; CANADA; COHORT ANALYSIS; DISEASE SEVERITY; FEMALE; GLOMERULUS FILTRATION RATE; HIGH RISK PATIENT; HUMAN; KIDNEY FUNCTION; LIFE EXPECTANCY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SENSITIVITY ANALYSIS;

EID: 84991035191     PISSN: None     EISSN: 20543581     Source Type: Journal    
DOI: 10.1186/s40697-014-0033-6     Document Type: Article

References (27)

1. Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int 2013, Suppl. 3:1-150.
2. Tonelli M, Wiebe N, Culleton B, House A, Rabbat C, Fok M, McAlister F, Garg AX: Chronic kidney disease and mortality risk: a systematic review. J AmSoc Nephrol 2006, 17:2034-2047.
3. Grimm RH Jr, Svendsen KH, Kasiske B, Keane WF, Wahi MM: Proteinuria is a risk factor for mortality over 10 years of follow-up. MRFIT Research Group. Multiple Risk Factor Intervention Trial. Kidney Int 1997, 63:S10-S14.
4. Hillege HL, Fidler V, Diercks GFH, van Gilst WH, de Zeeuw D, van Veldhuisen DJ, Gans ROB, Janssen WMT, Grobbee DE, de Jong PE: Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population. Circulation 2002, 106:1777-1782.
5. Turin TC, Tonelli M, Manns BJ, Ravani P, Ahmed SB, Hemmelgarn BR: Chronic kidney disease and life expectancy. Nephrol Dial Transplant 2012, 27:3182-3186.
6. Turin TC, Tonelli M, Manns BJ, Ahmed SB, Ravani P, James M, Hemmelgarn BR: Proteinuria and Life Expectancy. Am J Kidney Dis 2013, 61:646-648.
7. Hemmelgarn BR, Clement F, Manns BJ, Klarenbach S, James MT, Ravani P, Pannu N, Ahmed SB, MacRae J, Scott-Douglas N, Jindal K, Quinn R, Culleton BF, Wiebe N, Krause R, Thorlacius L, Tonelli M: Overview of the Alberta Kidney Disease Network. BMC Nephrol 2009, 10:30.
8. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J: A new equation to estimate glomerular filtration rate. Ann Intern Med 2009, 150:604-612.
9. Hemmelgarn BR, Manns BJ, Lloyd A, James MT, Klarenbach S, Quinn RR, Wiebe N, Tonelli M: Relation between kidney function, proteinuria, and adverse outcomes. JAMA 2010, 303:423-429.
10. Lamb EJ, MacKenzie F, Stevens PE: How should proteinuria be detected and measured? Ann Clin Biochem 2009, 46:205-217.
11. Norris K, Nissenson AR: Race, Gender, and Socioeconomic Disparities in CKD in the United States. J Am Soc Nephrol 2008, 19:1261-1270.
12. Breslow NE, Day NE: Statistical Methods in Cancer Research Volume II-The analysis of case-control studies. Lyon: International Agency for Research on Cancer; 1980:41-81. In.
13. Turin TC, Hemmelgarn BR: Long-term risk projection and its application to nephrology research. J Nephrol 2012, 25:441-449.
14. Turin TC, Rumana N, Okamura T: Residual lifetime risk of cardiovascular diseases in Japan. J Atheroscler Thromb 2011, 18:443-447.
15. Chiang CL: The life table and its applications. Malabar: Robert E. Krieger Publishing; 1984:137-167.
16. Edwards A, Elwyn G, Mulley A: Explaining risks: turning numerical data into meaningful pictures. BMJ 2002, 324:827-830.
17. Schwartz LM, Woloshin S, Welch HG: Risk Communication in Clinical Practice: Putting Cancer in Context. J Natl Cancer Inst Monogr 1999, 1999:124-133.
18. Fortin J, Hirota L, Bond B, O'Connor A, Col N: Identifying patient preferences for communicating risk estimates: A descriptive pilot study. BMC Med Inform Decis Mak 2001, 1:2.
19. Loukine L, Waters C, Choi BC, Ellison J: Health-Adjusted Life Expectancy among Canadian Adults with and without Hypertension. Cardiol Res Pract 2011, 2011:612968.
20. Kiiskinen U, Vartiainen E, Puska P, Aromaa A: Long-term cost and life-expectancy consequences of hypertension. J Hypertens 1998, 16:1103-1112.
21. Turin TC, Murakami Y, Miura K, Rumana N, Kita Y, Hayakawa T, Okamura T, Okayama A, Ueshima H: Hypertension and life expectancy among Japanese: NIPPON DATA80. Hypertens Res 2012, 35:954-958.
22. Franco OH, Peeters A, Bonneux L, De Laet C: Blood pressure in adulthood and life expectancy with cardiovascular disease in men and women: life course analysis. Hypertension 2005, 46:280-286.
23. Franco OH, Steyerberg EW, Hu FB, Mackenbach J, Nusselder W: Associations of diabetes mellitus with total life expectancy and life expectancy with and without cardiovascular disease. Arch Intern Med 2007, 167:1145-1151.
24. Gu K, Cowie CC, Harris MI: Mortality in adults with and without diabetes in a national cohort of the US population, 1971-1993. Diabetes Care 1998, 21:1138-1145.
25. Turin TC, Murakami Y, Miura K, Rumana N, Kadota A, Ohkubo T, Okamura T, Okayama A, Ueshima H: Diabetes and life expectancy among Japanese - NIPPON DATA80. Diabetes Res Clin Pract 2012, 96:e12-e22.
26. Statistics Canada. Life Tables, Canada, Provinces and Territories. Life expectancy at birth, by sex, by province 2006-2008 (Catalogue 84-537-XIE). Available at http://www5.statcan.gc.ca/olc-cel/olc.action?ObjId=84-537- X&ObjType=2&lang=en&limit=0 Accessed July 1, 2012.
27. Turin TC, James M, Ravani P, Tonelli M, Manns BJ, Quinn R, Jun M, Klarenbach S, Hemmelgarn BR: Proteinuria and rate of change in kidney function in a community-based population. J Am Soc Nephrol 2013, 24:1661-1667.